Clinical trial

SWITCH - Sensing With Insulin Pump Therapy to Control HbA1c

NCT00598663

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-01-01

PhaseNA

Study timeline

Study start (unknown)2008-01-01Date precision: month

Registry last updated2019-09-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 1unresolved

Interventions

insulin pump with continuous glucose sensing (Paradigm Real-Time Insulin Pump System)DEVICE

insulin pump and blinded continuous glucose sensing (Paradigm Real-Time insulin pump)DEVICE

Sponsors & collaborators

Medtronic MiniMed, Inc.lead sponsor

Mapped research locations

BarcelonaSpain1 ViennaAustria1 CopenhagenDenmark1 RomeItaly1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00598663 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.